Aptose Biosciences Performance
| APTODelisted Stock | USD 2.01 0.91 82.73% |
The firm shows a Beta (market volatility) of -2.59, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Aptose Biosciences are expected to decrease by larger amounts. On the other hand, during market turmoil, Aptose Biosciences is expected to outperform it. Aptose Biosciences right now shows a risk of 0.0%. Please confirm Aptose Biosciences treynor ratio, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if Aptose Biosciences will be following its price patterns.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Aptose Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Aptose Biosciences is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors. ...more
Aptose |
Aptose Biosciences Relative Risk vs. Return Landscape
If you would invest 201.00 in Aptose Biosciences on November 15, 2025 and sell it today you would earn a total of 0.00 from holding Aptose Biosciences or generate 0.0% return on investment over 90 days. Aptose Biosciences is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Aptose, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Aptose Biosciences Target Price Odds to finish over Current Price
The tendency of Aptose Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 2.01 | 90 days | 2.01 | about 97.0 |
Based on a normal probability distribution, the odds of Aptose Biosciences to move above the current price in 90 days from now is about 97.0 (This Aptose Biosciences probability density function shows the probability of Aptose Stock to fall within a particular range of prices over 90 days) .
Aptose Biosciences Price Density |
| Price |
Predictive Modules for Aptose Biosciences
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Aptose Biosciences. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Aptose Biosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Aptose Biosciences Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Aptose Biosciences is not an exception. The market had few large corrections towards the Aptose Biosciences' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Aptose Biosciences, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Aptose Biosciences within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -1.22 | |
β | Beta against Dow Jones | -2.59 | |
σ | Overall volatility | 1.51 | |
Ir | Information ratio | -0.14 |
Aptose Biosciences Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Aptose Biosciences for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Aptose Biosciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Aptose Biosciences is not yet fully synchronised with the market data | |
| Aptose Biosciences has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (25.43 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Aptose Biosciences currently holds about 62.41 M in cash with (35.98 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.68. | |
| Roughly 25.0% of the company shares are held by company insiders |
Aptose Biosciences Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Aptose Stock often depends not only on the future outlook of the current and potential Aptose Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Aptose Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 23.3 M | |
| Cash And Short Term Investments | 6.2 M |
Aptose Biosciences Fundamentals Growth
Aptose Stock prices reflect investors' perceptions of the future prospects and financial health of Aptose Biosciences, and Aptose Biosciences fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Aptose Stock performance.
| Return On Equity | -6.94 | |||
| Return On Asset | -1.42 | |||
| Current Valuation | 9.69 M | |||
| Shares Outstanding | 2.55 M | |||
| Price To Earning | (1.80) X | |||
| Price To Book | 67.84 X | |||
| EBITDA | (36.15 M) | |||
| Cash And Equivalents | 62.41 M | |||
| Cash Per Share | 0.68 X | |||
| Total Debt | 621 K | |||
| Debt To Equity | 0.01 % | |||
| Book Value Per Share | (14.04) X | |||
| Cash Flow From Operations | (35.98 M) | |||
| Earnings Per Share | (36.38) X | |||
| Total Asset | 10.13 M | |||
| Retained Earnings | (540.97 M) | |||
| Current Asset | 14.98 M | |||
| Current Liabilities | 1.7 M | |||
About Aptose Biosciences Performance
By examining Aptose Biosciences' fundamental ratios, stakeholders can obtain critical insights into Aptose Biosciences' financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Aptose Biosciences is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology primarily in the United States. Aptose Biosciences Inc. was incorporated in 1986 and is headquartered in Toronto, Canada. Aptose Bioscns operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 41 people.Things to note about Aptose Biosciences performance evaluation
Checking the ongoing alerts about Aptose Biosciences for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Aptose Biosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Aptose Biosciences is not yet fully synchronised with the market data | |
| Aptose Biosciences has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (25.43 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Aptose Biosciences currently holds about 62.41 M in cash with (35.98 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.68. | |
| Roughly 25.0% of the company shares are held by company insiders |
- Analyzing Aptose Biosciences' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Aptose Biosciences' stock is overvalued or undervalued compared to its peers.
- Examining Aptose Biosciences' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Aptose Biosciences' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Aptose Biosciences' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Aptose Biosciences' stock. These opinions can provide insight into Aptose Biosciences' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Consideration for investing in Aptose Stock
If you are still planning to invest in Aptose Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aptose Biosciences' history and understand the potential risks before investing.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |